CANCER RES TREAT 润色咨询

Cancer Research and Treatment

出版年份:暂无数据 年文章数:159 投稿命中率:26.67%

出版周期:Quarterly 自引率:4.7% 审稿周期:平均1月

前往期刊查询

投稿信息

投稿信息
审稿速度
平均1月 (网友贡献,非官方数据)
投稿命中率
26.67% (网友贡献,非官方数据)
审稿费用
暂无数据
版面费用
600.0元/篇 (网友贡献,非官方数据)
中国人发表比例
2019年中国人文章占该期刊总数量20.13% (2018年为12.77%)
自引率
4.7 %
年文章数
159
期刊官网
点击查看 (点击次数:5711)
点击查看 (点击次数:3285次)
作者需知
点击查看 (点击次数:391次)
期刊简介
稿件收录要求
Cancer Research and Treatment is a peer-reviewed open access publication of the Korean Cancer Association. It is published quarterly, one volume per year. Abbreviated title is Cancer Res Treat. It accepts manuscripts relevant to experimental and clinical cancer research. Subjects include carcinogenesis, tumor biology, molecular oncology, cancer genetics, tumor immunology, epidemiology, predictive markers and cancer prevention, pathology, cancer diagnosis, screening and therapies including chemotherapy, surgery, radiation therapy, immunotherapy, gene therapy, multimodality treatment and palliative care.
Cancer Research and Treatment (CRT) is indexed/tracked/covered by SCI, Medline, PubMed, PubMed Central, KoreaMed, CrossRef, Chemical Abstracts Service (CAS), SCOPUS, KoMCI, and Google Scholar.
打开APP